Home / Investors Information / EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France Read more about EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C. Read more about EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C. EDAP Announces Sale of Focal One(R) HIFU Device to Mannheim University Hospital, Germany Read more about EDAP Announces Sale of Focal One(R) HIFU Device to Mannheim University Hospital, Germany EDAP's Ablatherm(R)-HIFU Technology Highlighted at the World Congress of Endourology, Taiwan Read more about EDAP's Ablatherm(R)-HIFU Technology Highlighted at the World Congress of Endourology, Taiwan EDAP Reports Strong Growth in Its Second Quarter 2014 Results Read more about EDAP Reports Strong Growth in Its Second Quarter 2014 Results EDAP Highlights HIFU Expertise at 7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer Read more about EDAP Highlights HIFU Expertise at 7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results Read more about EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results EDAP Comments on FDA Panel Vote Read more about EDAP Comments on FDA Panel Vote EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer Read more about EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer EDAP Completes FDA Inspection of Manufacturing Site Read more about EDAP Completes FDA Inspection of Manufacturing Site Pagination First page « First Previous page ‹ Previous … Page 23 Page 24 Page 25 Page 26 Current page 27 Page 28 Page 29 Page 30 Page 31 … Next page Next › Last page Last » Subscribe to
EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France Read more about EDAP Announces Sale of Focal One(R) HIFU Device to Nantes-Atlantis Urology Clinic in France
EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C. Read more about EDAP Presents Results of Its Ablatherm-HIFU FDA Study at 4th International Symposium of the Focused Ultrasound Foundation, Washington D.C.
EDAP Announces Sale of Focal One(R) HIFU Device to Mannheim University Hospital, Germany Read more about EDAP Announces Sale of Focal One(R) HIFU Device to Mannheim University Hospital, Germany
EDAP's Ablatherm(R)-HIFU Technology Highlighted at the World Congress of Endourology, Taiwan Read more about EDAP's Ablatherm(R)-HIFU Technology Highlighted at the World Congress of Endourology, Taiwan
EDAP Reports Strong Growth in Its Second Quarter 2014 Results Read more about EDAP Reports Strong Growth in Its Second Quarter 2014 Results
EDAP Highlights HIFU Expertise at 7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer Read more about EDAP Highlights HIFU Expertise at 7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results Read more about EDAP Schedules Webcast and Conference Call for Second Quarter 2014 Results
EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer Read more about EDAP Updates on FDA Advisory Committee Meeting on Ablatherm-HIFU for the Treatment of Prostate Cancer
EDAP Completes FDA Inspection of Manufacturing Site Read more about EDAP Completes FDA Inspection of Manufacturing Site
